Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CVTX

CV Therapeutics (CVTX)

CV Therapeutics (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CVTX
DateTimeSourceHeadlineSymbolCompany
04/06/20096:01AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:CVTXCV Therapeutics (MM)
04/03/20096:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
04/03/20092:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
04/03/20092:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
04/03/20092:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
04/03/20092:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
04/03/20092:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
04/01/200912:59PMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:CVTXCV Therapeutics (MM)
04/01/20096:05AMEdgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:CVTXCV Therapeutics (MM)
03/26/20091:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CVTXCV Therapeutics (MM)
03/24/20092:43PMEdgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:CVTXCV Therapeutics (MM)
03/24/20092:33PMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:CVTXCV Therapeutics (MM)
03/18/20095:05PMMarketwiredCV Therapeutics' Board of Directors Recommends Stockholders Accept Gilead Sciences' $20.00 per Share Cash Tender OfferNASDAQ:CVTXCV Therapeutics (MM)
03/18/20094:44PMEdgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:CVTXCV Therapeutics (MM)
03/18/20094:42PMEdgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:CVTXCV Therapeutics (MM)
03/18/20091:53PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:CVTXCV Therapeutics (MM)
03/18/20091:52PMEdgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:CVTXCV Therapeutics (MM)
03/17/20099:07AMMarketwiredRun of 100% Profitable Stock Alerts Marches on for BullTradeNASDAQ:CVTXCV Therapeutics (MM)
03/16/20095:13PMEdgar (US Regulatory)Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A)NASDAQ:CVTXCV Therapeutics (MM)
03/16/20095:11PMEdgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:CVTXCV Therapeutics (MM)
03/16/20094:57PMDow Jones NewsMARKET SNAPSHOT: Corporate Cash Reserves, Cheap Stocks Could Trigger More M&ANASDAQ:CVTXCV Therapeutics Inc.
03/16/20094:01PMMarketwiredCV Therapeutics Announces Presentations at the American College of Cardiology 58th Annual Scientific SessionNASDAQ:CVTXCV Therapeutics (MM)
03/16/20093:01PMDow Jones NewsUPDATE: US Drug Sector Rises After Bernanke CommentsNASDAQ:CVTXCV Therapeutics Inc.
03/16/20092:49PMDow Jones NewsMARKET SNAPSHOT: Corporate Cash Warchests, Cheap Stocks Could Trigger More M&ANASDAQ:CVTXCV Therapeutics Inc.
03/16/200911:10AMDow Jones NewsDrug Sector Rises As Fed Chief Bernanke's Upbeat On RecessionNASDAQ:CVTXCV Therapeutics Inc.
03/16/20095:12AMDow Jones NewsUPDATE:Astellas Pharma Abandons Offer To Buy CV TherapeuticsNASDAQ:CVTXCV Therapeutics Inc.
03/16/20093:08AMDow Jones NewsAstellas Pharma: Withdrawing Offer To Buy CV TherapeuticsNASDAQ:CVTXCV Therapeutics Inc.
03/16/20092:42AMBusiness WireAstellas to Terminate Offer for CV TherapeuticsNASDAQ:CVTXCV Therapeutics (MM)
03/13/20098:45AMDow Jones NewsGenentech-Roche Deal Shows Attraction Of Biotech AssetsNASDAQ:CVTXCV Therapeutics Inc.
03/12/20095:03PMEdgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:CVTXCV Therapeutics (MM)
 Showing the most relevant articles for your search:NASDAQ:CVTX